Focus Partners Advisor Solutions’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.36M Buy
31,754
+5,502
+21% +$299K 0.01% 471
2026
Q1
$1.65M Buy
26,252
+17,460
+199% +$1.4M 0.02% 404
2025
Q4
$838K Sell
8,792
-1,731
-16% -$170K 0.01% 548
2025
Q3
$1.05M Sell
10,523
-2,886
-22% -$299K 0.01% 502
2025
Q2
$1.44M Buy
13,409
+1,186
+10% +$120K 0.02% 348
2025
Q1
$1.23M Buy
12,223
+1,034
+9% +$104K 0.02% 335
2024
Q4
$999K Sell
11,189
-180
-2% -$15.8K 0.02% 333
2024
Q3
$953K Sell
11,369
-940
-8% -$74.1K 0.02% 301
2024
Q2
$948K Sell
12,309
-44
-0.4% -$3.22K 0.02% 256
2024
Q1
$846K Buy
12,353
+2,752
+29% +$177K 0.02% 263
2023
Q4
$555K Buy
9,601
+72
+0.8% +$3.84K 0.03% 238
2023
Q3
$503K Buy
9,529
+90
+1% +$4.72K 0.02% 258
2023
Q2
$511K Buy
9,439
+14
+0.1% +$731 0.03% 214
2023
Q1
$472K Sell
9,425
-875
-8% -$41.2K 0.03% 209
2022
Q4
$477K Sell
10,300
-1,471
-12% -$63.7K 0.04% 196
2022
Q3
$456K Buy
+11,771
New +$472K 0.03% 237
2022
Q2
Sell
-5,270
Closed -$232K 365
2022
Q1
$232K Buy
+5,270
New +$228K 0.02% 286

Other funds holding BSX

Focus Partners Advisor Solutions's BSX Position: Q2 2026 in Review

Focus Partners Advisor Solutions increased its Boston Scientific (BSX) stake by 21% in Q2 2026, buying an estimated $299K and bringing the position to 31,754 shares worth $1.36M. The position accounts for 0.01% of the portfolio, ranked #471.

Focus Partners Advisor Solutions first reported a position in BSX in Q1 2022 and has held it in 17 quarters since. The position peaked at $1.65M in Q1 2026. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Focus Partners Advisor Solutions held 31,754 shares of Boston Scientific worth $1.36M as of Q2 2026.
  • Focus Partners Advisor Solutions bought 5,502 Boston Scientific shares in Q2 2026, an estimated $299K.
  • Boston Scientific made up 0.01% of Focus Partners Advisor Solutions's portfolio in Q2 2026, its #471 holding.
  • Focus Partners Advisor Solutions first reported a position in Boston Scientific in Q1 2022 and has held it in 17 quarters since.
  • Focus Partners Advisor Solutions's Boston Scientific position peaked at $1.65M in Q1 2026.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q2 2026, filed 6 Aug 2026.